Dose Cancer Research Results
Dose, Dosage: Click to Expand ⟱
| Source: |
| Type: |
Drug dosage vs efficacy, and actual dosage number of research papers.
|
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
T47D |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
PDKs↓, eff↑, ROS↑, PDK1↓, lactateProd↓, p‑PDH↑, Dose∅, OCR↑, DNA-PK↑, γH2AX↑, cl‑PARP↑, selectivity↑, *toxicity∅,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
eff↑, Dose∅, *BioAv↑, selectivity↑, TumCP↓, Casp↑, PTEN↑, TSC1↑, mTOR⇅, Akt↓, PDK1↓, E6↓, E7↓, DNAdam↑, ROS↑, *BioAv↓, *BioEnh↑, *Half-Life∅,
QoL↑, OS↑, Dose∅, antiOx↑, ROS↑, SOD↑, Catalase↑, GPx↑, Risk↓, NK cell↑, IL1β↓, IL6↓, TNF-α↓, radioP↑, chemoP↑, TumVol↓, TumMeta↓, angioG↓, ChemoSen↑, eff↑,
ChemoSen↓, RadioS↑, Inflam↓, AntiCan↑, Dose∅, mtDam↑, Apoptosis?, OCR↓, ATP↓, ROS↑, ROS↑, LDH↓, TP53↓, Casp3↓, BAX↓, P21↓, ROS↑, eNOS↑, iNOS↑, eff↑, hTERT/TERT↓, cycD1/CCND1↓, eff↑, eff↑, eff↑, eff↑, STAT3↓, TIMP1↓, IL4↓, IL10↓, OS↑, Dose∅, ER Stress↑, ROS↑, NF-kB↓, p65↓, MMP↓, TumAuto↑, LC3II↑, p62↓, TLR4↓, mtDam↑, LDH↓, ROS↑, Glycolysis↓, HK2↓, PFK↓, PKM2↓, LDH↓, IL10↓, HDAC8↓, eff↑, eff↑, P21↑,
OS↑, eff↑, Dose∅, *toxicity↝, eff↑,
Pain↓, Strength↑, QoL↑, Dose∅,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, Catalase↑, 1, GPx↑, 1, ROS↑, 8, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MMP↓, 1, mtDam↑, 2, OCR↓, 1, OCR↑, 1,
Core Metabolism/Glycolysis ⓘ
Glycolysis↓, 1, HK2↓, 1, lactateProd↓, 1, LDH↓, 3, p‑PDH↑, 1, PDK1↓, 2, PDKs↓, 1, PFK↓, 1, PKM2↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis?, 1, BAX↓, 1, Casp↑, 1, Casp3↓, 1, hTERT/TERT↓, 1, iNOS↑, 1,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1,
Autophagy & Lysosomes ⓘ
LC3II↑, 1, p62↓, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNA-PK↑, 1, DNAdam↑, 1, cl‑PARP↑, 1, TP53↓, 1, γH2AX↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, P21↓, 1, P21↑, 1,
Proliferation, Differentiation & Cell State ⓘ
HDAC8↓, 1, mTOR⇅, 1, PTEN↑, 1, STAT3↓, 1,
Migration ⓘ
TIMP1↓, 1, TSC1↑, 1, TumCP↓, 1, TumMeta↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, eNOS↑, 1,
Immune & Inflammatory Signaling ⓘ
IL10↓, 2, IL1β↓, 1, IL4↓, 1, IL6↓, 1, Inflam↓, 1, NF-kB↓, 1, NK cell↑, 1, p65↓, 1, TLR4↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↓, 1, ChemoSen↑, 1, Dose∅, 7, eff↑, 12, RadioS↑, 1, selectivity↑, 2,
Clinical Biomarkers ⓘ
E6↓, 1, E7↓, 1, hTERT/TERT↓, 1, IL6↓, 1, LDH↓, 3, TP53↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, chemoP↑, 1, OS↑, 3, Pain↓, 1, QoL↑, 2, radioP↑, 1, Risk↓, 1, Strength↑, 1, TumVol↓, 1,
Total Targets: 79
Pathway results for Effect on Normal Cells:
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, BioEnh↑, 1, Half-Life∅, 1,
Functional Outcomes ⓘ
toxicity↝, 1, toxicity∅, 1,
Total Targets: 6
Scientific Paper Hit Count for: Dose, Dosage
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:1114 State#:% Dir#:6
wNotes=0 sortOrder:rid,rpid
Home Page